• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清脂蛋白(a)水平和胰岛素抵抗对脂肪肝疾病有相反的影响。

Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease.

机构信息

Department of Endocrinology and Metabolism, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Department of Endocrinology and Metabolism, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.

出版信息

Atherosclerosis. 2020 Sep;308:1-5. doi: 10.1016/j.atherosclerosis.2020.07.020. Epub 2020 Jul 30.

DOI:10.1016/j.atherosclerosis.2020.07.020
PMID:32771802
Abstract

BACKGROUND AND AIMS

High lipoprotein(a) [Lp(a)] levels are associated with increased risk of cardiovascular disease. However, the association between Lp(a) and fatty liver disease (FLD) remains controversial. Therefore, we analyzed the relationship between FLD and serum Lp(a) levels in Korean adults.

METHODS

A total of 22,534 participants who underwent a routine health screening program at Kangbuk Samsung Hospital in 2010 and 2014 were enrolled. Anthropometric and biochemical parameters, including Lp(a), were measured. The presence of FLD was assessed using abdominal ultrasonography. Odds ratios (ORs) for the presence of FLD were analyzed in quartile groups of serum Lp(a) levels using logistic regression. We divided the participants into four groups according to the median values of Lp(a) and homeostasis model assessment for insulin resistance (HOMA-IR).

RESULTS

Among the total study population, 3030 (13.4%) participants had fatty liver disease. The mean Lp(a) level was lower in subjects with FLD than in those without (70.0 vs 73.8 nmol/L, p < 0.001). The OR for FLD was the lowest in the fourth Lp(a) quartile group, using the first quartile group as the reference group after adjusting for confounding factors [0.815; 95% confidence interval (CI) 0.725-0.916]. When the OR for FLD was analyzed in four groups divided by the median values of Lp(a) and HOMA-IR, the low Lp(a)-high HOMA-IR group had the greatest OR for FLD, using the high Lp(a)-low HOMA-IR group as the reference (1.903; 95% CI 1.679-2.158).

CONCLUSIONS

Serum Lp(a) levels were inversely associated with the presence of FLD. Subjects with low Lp(a) and high insulin resistance (IR) showed higher risk of FLD than those with high Lp(a) and low IR, suggesting the opposite associations of Lp(a) and IR with FLD.

摘要

背景与目的

高脂蛋白(a) [Lp(a)]水平与心血管疾病风险增加相关。然而,Lp(a)与脂肪肝疾病 (FLD)之间的关系仍存在争议。因此,我们分析了韩国成年人中 FLD 与血清 Lp(a)水平之间的关系。

方法

共纳入 2010 年和 2014 年在 Kangbuk Samsung 医院进行常规健康筛查的 22534 名参与者。测量了包括 Lp(a)在内的人体测量和生化参数。使用腹部超声评估 FLD 的存在。使用逻辑回归分析了按血清 Lp(a)水平四分位组划分的 FLD 存在的优势比 (OR)。我们根据 Lp(a)和胰岛素抵抗的稳态模型评估 (HOMA-IR) 的中位数将参与者分为四组。

结果

在总研究人群中,3030 名(13.4%)参与者患有脂肪肝疾病。与无 FLD 者相比,FLD 患者的 Lp(a)平均水平较低(70.0 与 73.8 nmol/L,p < 0.001)。在调整混杂因素后,使用四分位组 1 作为参考组,第四 Lp(a)四分位组的 FLD 比值比最低[0.815;95%置信区间 (CI) 0.725-0.916]。当根据 Lp(a)和 HOMA-IR 的中位数将参与者分为四组进行分析时,使用高 Lp(a)-低 HOMA-IR 组作为参考,低 Lp(a)-高 HOMA-IR 组的 FLD 比值比最大(1.903;95%CI 1.679-2.158)。

结论

血清 Lp(a)水平与 FLD 的存在呈负相关。Lp(a)水平低且胰岛素抵抗 (IR) 高的患者发生 FLD 的风险高于 Lp(a)水平高且 IR 低的患者,这表明 Lp(a)和 IR 与 FLD 的关联相反。

相似文献

1
Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease.血清脂蛋白(a)水平和胰岛素抵抗对脂肪肝疾病有相反的影响。
Atherosclerosis. 2020 Sep;308:1-5. doi: 10.1016/j.atherosclerosis.2020.07.020. Epub 2020 Jul 30.
2
Association between lipoprotein(a) and nonalcoholic fatty liver disease among Korean adults.韩国成年人中脂蛋白(a)与非酒精性脂肪性肝病之间的关联。
Clin Chim Acta. 2016 Oct 1;461:14-8. doi: 10.1016/j.cca.2016.07.003. Epub 2016 Jul 6.
3
Insulin resistance contributes more to the increased risk for diabetes development in subjects with low lipoprotein(a) level than insulin secretion.与胰岛素分泌相比,胰岛素抵抗在脂蛋白(a)水平较低的受试者中对糖尿病发生风险增加的影响更大。
PLoS One. 2017 May 16;12(5):e0177500. doi: 10.1371/journal.pone.0177500. eCollection 2017.
4
Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.γ-谷氨酰转移酶是孟加拉国成年人胰岛素抵抗与非酒精性脂肪性肝病关联的独立决定因素:γ-谷氨酰转移酶和胰岛素抵抗指数与非酒精性脂肪性肝病的关联
Diabetes Metab Syndr. 2016 Jan-Mar;10(1 Suppl 1):S25-9. doi: 10.1016/j.dsx.2015.09.005. Epub 2015 Oct 9.
5
Effect of the Interaction between Obstructive Sleep Apnea and Lipoprotein(a) on Insulin Resistance: A Large-Scale Cross-Sectional Study.阻塞性睡眠呼吸暂停与脂蛋白(a)相互作用对胰岛素抵抗的影响:一项大规模横断面研究。
J Diabetes Res. 2019 Apr 8;2019:9583286. doi: 10.1155/2019/9583286. eCollection 2019.
6
High levels of lipoprotein(a) are associated with a lower prevalence of diabetes with advancing age: results of a cross-sectional epidemiological survey in Gran Canaria, Spain.脂蛋白(a)水平升高与年龄增长相关的糖尿病患病率降低有关:西班牙大加那利岛的横断面流行病学调查结果。
Cardiovasc Diabetol. 2012 Jul 2;11:81. doi: 10.1186/1475-2840-11-81.
7
Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease.脂蛋白胰岛素抵抗指数反映非酒精性脂肪肝患者肝内脂肪含量。
Hepatol Commun. 2020 Dec 29;5(4):589-597. doi: 10.1002/hep4.1658. eCollection 2021 Apr.
8
Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.非酒精性脂肪性肝病与代谢综合征的关联独立于中心性肥胖和胰岛素抵抗。
Sci Rep. 2016 Jun 1;6:27034. doi: 10.1038/srep27034.
9
Positive association between insulin resistance and fatty liver disease in psoriasis: evidence from a cross-sectional study.银屑病患者中胰岛素抵抗与脂肪肝之间存在正相关关系:来自横断面研究的证据。
Front Immunol. 2024 Apr 23;15:1388967. doi: 10.3389/fimmu.2024.1388967. eCollection 2024.
10
Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor.非酒精性脂肪性肝炎的晚期纤维化影响脂蛋白(a)作为心血管危险因素的重要性。
Atherosclerosis. 2020 Apr;299:32-37. doi: 10.1016/j.atherosclerosis.2020.02.026. Epub 2020 Mar 7.

引用本文的文献

1
Rethinking cardiovascular risk: The emerging role of lipoprotein(a) screening.重新审视心血管风险:脂蛋白(a)筛查的新作用。
Am J Prev Cardiol. 2025 Feb 14;21:100945. doi: 10.1016/j.ajpc.2025.100945. eCollection 2025 Mar.
2
Non-alcoholic fatty liver disease: Dietary and nutraceutical approaches.非酒精性脂肪性肝病:饮食与营养补充剂疗法
Liver Res. 2023 Aug 25;7(3):216-227. doi: 10.1016/j.livres.2023.08.005. eCollection 2023 Sep.
3
Association between galectin-3 and hepatosteatosis in a community-based cross-sectional study.
一项基于社区的横断面研究中半乳糖凝集素-3与肝脂肪变性的关联。
Ther Adv Chronic Dis. 2024 Nov 30;15:20406223241302719. doi: 10.1177/20406223241302719. eCollection 2024.
4
Circulating lipoprotein(a) in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.非酒精性脂肪性肝病患者循环脂蛋白(a):一项系统评价和荟萃分析。
J Gastroenterol Hepatol. 2024 Dec;39(12):2572-2581. doi: 10.1111/jgh.16768. Epub 2024 Oct 17.
5
The implications of measuring lipoprotein(a) in clinical practice.临床实践中测量脂蛋白(a)的意义。
Glob Cardiol Sci Pract. 2024 Aug 1;2024(4):e202440. doi: 10.21542/gcsp.2024.40.
6
Lipoprotein(a) level predicts the development of nonalcoholic fatty liver disease in Korean adults: A retrospective longitudinal study.脂蛋白(a)水平可预测韩国成年人非酒精性脂肪性肝病的发生:一项回顾性纵向研究。
Medicine (Baltimore). 2024 May 31;103(22):e38340. doi: 10.1097/MD.0000000000038340.
7
Associations of very low Lipoprotein(a) levels with risks of new-onset diabetes and non-alcoholic liver disease.极低脂蛋白(a)水平与新发糖尿病和非酒精性肝病风险的关联。
Atheroscler Plus. 2024 Jul 11;57:19-25. doi: 10.1016/j.athplu.2024.07.001. eCollection 2024 Sep.
8
Relationship Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Lipoprotein (a) and Other Biomarkers.代谢功能障碍相关脂肪性肝病与脂蛋白(a)及其他生物标志物之间的关系
Cureus. 2024 Jun 24;16(6):e63019. doi: 10.7759/cureus.63019. eCollection 2024 Jun.
9
Positive association between insulin resistance and fatty liver disease in psoriasis: evidence from a cross-sectional study.银屑病患者中胰岛素抵抗与脂肪肝之间存在正相关关系:来自横断面研究的证据。
Front Immunol. 2024 Apr 23;15:1388967. doi: 10.3389/fimmu.2024.1388967. eCollection 2024.
10
Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels.波兰心脏病学会(PCS)和波兰脂质协会(PoLA)专家关于脂蛋白(a)水平升高的诊断和管理的建议。
Arch Med Sci. 2024 Jan 31;20(1):8-27. doi: 10.5114/aoms/183522. eCollection 2024.